{
    "clinical_study": {
        "@rank": "65446", 
        "arm_group": [
            {
                "arm_group_label": "Intermittent bolus injection of propofol", 
                "arm_group_type": "Active Comparator", 
                "description": "A loading dose of 2 mg of midazolam and 0.4 mg/kg of propofol is initially injected and then repeated intermittent bolus injection of 20 mg of propofol is followed according to patients' sedation level."
            }, 
            {
                "arm_group_label": "Continuous infusion of propofol", 
                "arm_group_type": "Active Comparator", 
                "description": "Propofol is continuously administered intravenously via infusion pump starting with 20 mg/kg/hr and then titrated to about 5 mg/kg/hr according to patients' sedation level."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to compare sedation efficiency, safety and satisfaction by both\n      endoscopist, assistants, and the patients between continuous infusion and intermittent bolus\n      injection of propofol for deep sedation during ERCP."
        }, 
        "brief_title": "Comparison Between Continuous Infusion and Intermittent Bolus Injection of Propofol for Deep Sedation During ERCP", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Biliary Tract Diseases", 
            "Pancreatic Diseases"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Biliary Tract Diseases", 
                "Pancreatic Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "The patients undergone ERCP were randomly assigned to either continuous infusion of propofol\n      (continuous group) or midazolam plus intermittent bolus injection of propofol (intermittent\n      group) for deep sedation. In the continuous group, propofol was continuously administered\n      via infusion pump and the doses were determined by sedation assistants monitoring the\n      patients. In the intermittent group, a loading dose of 2 mg of midazolam and 0.4 mg/kg of\n      propofol was initially injected and repeated bolus injection of 20 mg of propofol was\n      followed according to patients' sedation level. Sedation related parameters (total dose of\n      propofol, induction/recovery time, patients' cooperation) and adverse events during the\n      procedure were evaluated. Satisfaction scores by endoscopist, assistant, and patients and\n      difficulty scores of maintaining the sedation by assistants were also graded after the\n      procedure."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients undergone ERCP for biliary and pancreatic diseases\n\n        Exclusion Criteria:\n\n          -  Comorbid conditions of ASA class 4-5\n\n          -  Age under 18 years or over 90 years\n\n          -  Pregnancy\n\n          -  Past medication history of benzodiazepine or narcotics\n\n          -  Known allergy to midazolam or propofol\n\n          -  hypotension (systolic blood pressure <90 mmHg), hypoxemia (SaO2 <90%), or bradycardia\n             (50/min) at baseline measurements"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "210", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01900938", 
            "org_study_id": "2012-055"
        }, 
        "intervention": [
            {
                "arm_group_label": "Continuous infusion of propofol", 
                "description": "Propofol is continuously administered intravenously via infusion pump starting with 20 mg/kg/hr and then titrated to about 5 mg/kg/hr according to patients' sedation level.", 
                "intervention_name": "Continuous infusion of propofol", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Intermittent bolus injection of propofol", 
                "description": "A loading dose of 2 mg of midazolam and 0.4 mg/kg of propofol is initially injected and then repeated intermittent bolus injection of 20 mg of propofol is followed according to patients' sedation level.", 
                "intervention_name": "Intermittent bolus injection of propofol", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Intermittent bolus injection of propofol", 
                "intervention_name": "Midazolam", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Intermittent bolus injection of propofol", 
                    "Continuous infusion of propofol"
                ], 
                "intervention_name": "Propofol", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Midazolam", 
                "Propofol"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cholangiopancreatography", 
            "Endoscopic Retrograde"
        ], 
        "lastchanged_date": "July 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Guri", 
                    "country": "Korea, Republic of", 
                    "state": "Gyeonggi", 
                    "zip": "471-701"
                }, 
                "name": "Hanyang University Guri Hospital"
            }, 
            "investigator": {
                "last_name": "Kyo-Sang Yoo, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison Between Continuous Infusion and Intermittent Bolus Injection of Propofol for Deep Sedation During Endoscopic Retrograde Cholangiopancreatography: a Prospective Randomized Controlled Study", 
        "overall_contact": {
            "email": "kyoo@hanyang.ac.kr", 
            "last_name": "Kyo-Sang Yoo, MD, PhD", 
            "phone": "82-31-560-2178"
        }, 
        "overall_official": {
            "affiliation": "Hanyang University", 
            "last_name": "Kyo-Sang Yoo", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Satisfaction scores by endoscopist", 
            "safety_issue": "No", 
            "time_frame": "30 minutes after the procedure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01900938"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hanyang University", 
            "investigator_full_name": "Kyo-Sang Yoo", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Adverse events for sedation", 
                "safety_issue": "Yes", 
                "time_frame": "1 day after the procedure"
            }, 
            {
                "measure": "Difficulty scores of maintaining the sedation", 
                "safety_issue": "No", 
                "time_frame": "30 minutes after the procedure"
            }
        ], 
        "source": "Hanyang University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hanyang University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}